Association between each demographic or healthy lifestyle factor and the use of verified medications among subjects with hyperlipidaemia recommended/indicated pharmacological treatments (N=9195): OR was calculated comparing lipid-lowering drug users versus non-users*
| Demographic or healthy lifestyle factors | Adjusted OR (95% CI)‡ | p Value |
| Education > 12 years | 1.1 (1.0 to 1.2) | 0.3 |
| Non-impoverished | 1.1 (1.0 to 1.3) | 0.06 |
| Smoking, Not current | 1.0 (0.9 to 1.1) | 0.9 |
| Alcohol <5 drinks | 0.9 (0.8 to 1.0) | 0.04 |
| Body mass index <25 | 0.7 (0.7 to 0.8) | <0.0001 |
| Physical activity >150 min/week | 1.3 (1.1 to 1.5) | <0.0001 |
| Reported health, Excellent/very good | 1.0 (0.9 to 1.1) | 0.7 |
| Multivitamin use | 1.0 (0.9 to 1.1) | 1 |
| Dietary variables | ||
| DASH accordance | 1.0 (0.8 to 1.1) | 0.8 |
| Total fat | 1.0 (0.9 to 1.2) | 0.4 |
| Saturated fat | 0.9 (0.8 to 1.1) | 0.4 |
| Protein | 1.1 (0.9 to 1.2) | 0.3 |
| Fibre | 1.0 (0.9 to 1.1) | 0.9 |
| Cholesterol | 1.0 (0.9 to 1.1) | 0.7 |
| Calcium | 1.1 (0.9 to 1.2) | 0.3 |
| Magnesium | 1.1 (1.0 to 1.2) | 0.2 |
| Potassium | 1.1 (0.9 to 1.3) | 0.1 |
| Sodium | 0.9 (0.7 to 1.0) | 0.02 |
*Users of statins or non-statin lipid-lowering agents.
†2122 LLD users and 7077 non-users.
‡Adjusted for age, gender, race, diabetes, cardiovascular disease (angina, congestive heart failure and cerebrovascular disease) and other comorbid conditions (cancer, arthritis and chronic obstructive pulmonary disease).
DASH, Dietary Approach to Stop Hypertension.